- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-Programmed Cell Death 1 (anti-PD1)
Total 161357 results
-
University of ZurichIncyte CorporationNot yet recruitingExanthema | Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
-
Abramson Cancer Center at Penn MedicineXencor, Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
Daniela Matei, MDMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedEndometrial Cancer | Endometrial AdenocarcinomaUnited States
-
Centre Hospitalier Universitaire de BesanconRecruiting
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
CStone PharmaceuticalsCompleted
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Sun Yat-sen UniversityRecruitingAdvanced Hepatocellular Carcinoma | Bevacizumab | Anti-PD1/PDL1 AntibodyChina
-
Maastricht Radiation OncologyMaastricht University Medical Center; Zuyderland Medical CentreCompleted
-
PfizerTerminatedGastrointestinal Tumors | Esophageal Adenocarcinomas | Colorectal Adenocarcinomas | Gastric AdenocarcinomasUnited States, Australia, Japan
-
Xinqiao Hospital of ChongqingTCRCure Biopharma Ltd.RecruitingHead and Neck Squamous Cell CarcinomaChina
-
Centre Hospitalier Universitaire de NiceRecruitingMetastatic MelanomaFrance
-
The Second Affiliated Hospital of Shandong First...Recruiting
-
University of PennsylvaniaIncyte CorporationActive, not recruiting
-
Bioray LaboratoriesFirst Affiliated Hospital of Zhejiang UniversityCompleted
-
Highlight TherapeuticsPivotal S.L.Completed
-
Dr Tan-to CHEUNGCompleted
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-Small Cell Lung CancerChina
-
Sun Yat-sen UniversitySecond Affiliated Hospital of Guangzhou Medical UniversityCompletedLiver Diseases | Hepatocellular Carcinoma | Anti-PD1 AntibodyChina
-
Merck Sharp & Dohme LLCCompleted
-
Zhejiang UniversityBioray LaboratoriesCompletedCastrate-Resistant Prostate CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin LymphomaUnited States, Brazil, Colombia, Czechia, France, Germany, Greece, Guatemala, Italy, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, United Kingdom
-
Adagene IncActive, not recruitingAdvanced/Metastatic Solid TumorsUnited States, Australia
-
Hadassah Medical OrganizationUnknown
-
Shenzhen Second People's HospitalUnknownMultiple Myeloma in RelapseChina
-
Adagene IncRecruitingAdvanced/Metastatic Solid TumorsSingapore, Australia, United States
-
Centre Hospitalier Universitaire de BesanconNovartis; National Cancer Institute, FranceRecruitingSquamous Cell Anal Carcinoma | Metastatic Squamous Cell CarcinomaFrance
-
Bristol-Myers SquibbActive, not recruitingNeoplasms by SiteUnited States, Australia, Denmark, France, Switzerland, Austria, Canada, Germany, Japan, Netherlands, Norway, Spain, United Kingdom, Finland, Italy
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditionsUnited States, Finland
-
Oncovir, Inc.Chevy Chase Healthcare, Chevy Chase MD; Mt. Sinai School of Medicine, New York... and other collaboratorsTerminated
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingLocally Advanced Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Oncocytic CarcinomaUnited States
-
Leiden UniversityBristol-Myers SquibbActive, not recruitingEffects of Immunotherapy | Adverse Drug Event | Toxicity, DrugNetherlands
-
Hospices Civils de LyonCompleted
-
BiocadRecruitingMelanoma (Skin) | Melanoma Stage IIIRussian Federation, Belarus
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Fundacion para la Investigacion Biomedica del Hospital...Recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
Merck Sharp & Dohme LLCTerminated
-
Icahn School of Medicine at Mount SinaiRecruitingNon-Small Cell Lung CancerUnited States
-
The Lymphoma Academic Research OrganisationCompletedHodgkin Lymphoma | Coexisting Medical ConditionsFrance, Belgium
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Huabo Biopharm Co., Ltd.Recruiting
-
Imugene LimitedActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma LungUnited States, Australia